| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 29 | 2022 | 3420 | 2.750 |
Why?
|
| Myocarditis | 17 | 2024 | 802 | 2.420 |
Why?
|
| Lymphocyte Activation | 38 | 2019 | 5503 | 1.690 |
Why?
|
| Cannabinoids | 7 | 2017 | 174 | 1.550 |
Why?
|
| Receptors, Antigen, T-Cell | 19 | 2023 | 2571 | 1.450 |
Why?
|
| Receptors, LDL | 11 | 2016 | 492 | 1.450 |
Why?
|
| T-Lymphocytes | 32 | 2022 | 10264 | 1.430 |
Why?
|
| Th1 Cells | 18 | 2017 | 1040 | 1.380 |
Why?
|
| Receptor, Cannabinoid, CB1 | 5 | 2017 | 137 | 1.320 |
Why?
|
| CD4-Positive T-Lymphocytes | 18 | 2021 | 4410 | 1.220 |
Why?
|
| Interferon-gamma | 15 | 2013 | 3158 | 1.180 |
Why?
|
| Arteriosclerosis | 10 | 2005 | 1055 | 1.120 |
Why?
|
| Aortic Diseases | 3 | 2018 | 741 | 1.050 |
Why?
|
| Macrophages | 16 | 2024 | 5783 | 1.030 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 14 | 2018 | 975 | 0.990 |
Why?
|
| Th2 Cells | 15 | 2016 | 1078 | 0.920 |
Why?
|
| Endothelium, Vascular | 15 | 2014 | 4424 | 0.900 |
Why?
|
| T-Lymphocytes, Cytotoxic | 6 | 2021 | 1802 | 0.890 |
Why?
|
| Piperidines | 9 | 2017 | 1663 | 0.890 |
Why?
|
| T-Lymphocyte Subsets | 13 | 2019 | 1814 | 0.860 |
Why?
|
| Adaptive Immunity | 6 | 2017 | 734 | 0.850 |
Why?
|
| Mice, Knockout | 35 | 2021 | 14471 | 0.770 |
Why?
|
| Mice, Inbred C57BL | 47 | 2024 | 22352 | 0.760 |
Why?
|
| Monoacylglycerol Lipases | 3 | 2021 | 30 | 0.750 |
Why?
|
| Dendritic Cells | 9 | 2022 | 2747 | 0.740 |
Why?
|
| Disease Models, Animal | 23 | 2024 | 18330 | 0.730 |
Why?
|
| Lymphocytes | 8 | 2017 | 2605 | 0.720 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2016 | 505 | 0.720 |
Why?
|
| Mice | 99 | 2024 | 81889 | 0.710 |
Why?
|
| Interleukin-12 | 9 | 2007 | 581 | 0.700 |
Why?
|
| Inflammation | 23 | 2018 | 10860 | 0.690 |
Why?
|
| CD8-Positive T-Lymphocytes | 15 | 2021 | 4652 | 0.690 |
Why?
|
| E-Selectin | 10 | 2019 | 575 | 0.690 |
Why?
|
| Immunity, Innate | 9 | 2021 | 3077 | 0.680 |
Why?
|
| Animals | 128 | 2024 | 168930 | 0.680 |
Why?
|
| Cell Movement | 14 | 2021 | 5199 | 0.670 |
Why?
|
| Interleukin-4 | 15 | 2000 | 1155 | 0.660 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 179 | 0.630 |
Why?
|
| Neutrophils | 8 | 2022 | 3782 | 0.600 |
Why?
|
| Interleukin-2 | 12 | 2015 | 1895 | 0.600 |
Why?
|
| T-Lymphocytes, Regulatory | 11 | 2018 | 3114 | 0.600 |
Why?
|
| P-Selectin | 8 | 2006 | 598 | 0.590 |
Why?
|
| Autoimmune Diseases | 4 | 2020 | 2254 | 0.590 |
Why?
|
| Th17 Cells | 5 | 2020 | 790 | 0.590 |
Why?
|
| Hypercholesterolemia | 5 | 2012 | 1145 | 0.580 |
Why?
|
| Lipoproteins, LDL | 4 | 2016 | 642 | 0.570 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2024 | 347 | 0.560 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 992 | 0.560 |
Why?
|
| Mice, Transgenic | 24 | 2022 | 9547 | 0.550 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 243 | 0.550 |
Why?
|
| Benzodioxoles | 2 | 2015 | 80 | 0.550 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2013 | 513 | 0.530 |
Why?
|
| Vaccines | 2 | 2023 | 842 | 0.520 |
Why?
|
| Antigens, CD | 7 | 2024 | 4032 | 0.520 |
Why?
|
| Adoptive Transfer | 10 | 2018 | 828 | 0.510 |
Why?
|
| Pyrazoles | 7 | 2017 | 2030 | 0.510 |
Why?
|
| Lipoprotein Lipase | 1 | 2016 | 133 | 0.500 |
Why?
|
| Antigens, Surface | 3 | 2011 | 1617 | 0.490 |
Why?
|
| Neutrophil Infiltration | 2 | 2022 | 392 | 0.490 |
Why?
|
| Membrane Glycoproteins | 9 | 2012 | 3702 | 0.480 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2015 | 306 | 0.470 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2011 | 1150 | 0.450 |
Why?
|
| Blood Platelets | 2 | 2022 | 2465 | 0.440 |
Why?
|
| Analgesics | 3 | 2021 | 1068 | 0.430 |
Why?
|
| Cholesterol, Dietary | 2 | 2011 | 224 | 0.430 |
Why?
|
| Cell Adhesion | 12 | 2016 | 3093 | 0.430 |
Why?
|
| Cytokines | 20 | 2021 | 7438 | 0.430 |
Why?
|
| Autoantibodies | 2 | 2021 | 2115 | 0.420 |
Why?
|
| Amidohydrolases | 3 | 2021 | 160 | 0.420 |
Why?
|
| Enzyme Inhibitors | 4 | 2021 | 3721 | 0.420 |
Why?
|
| Molecular Mimicry | 1 | 2014 | 212 | 0.420 |
Why?
|
| Signal Transduction | 17 | 2024 | 23619 | 0.420 |
Why?
|
| Immunity, Cellular | 4 | 2016 | 1560 | 0.410 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2014 | 4349 | 0.410 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 1331 | 0.400 |
Why?
|
| Endothelial Cells | 5 | 2019 | 3581 | 0.390 |
Why?
|
| Antigen-Presenting Cells | 10 | 2015 | 960 | 0.390 |
Why?
|
| Cells, Cultured | 25 | 2019 | 18984 | 0.380 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2015 | 627 | 0.380 |
Why?
|
| Heart | 5 | 2019 | 4425 | 0.380 |
Why?
|
| Antigen Presentation | 5 | 2021 | 1250 | 0.380 |
Why?
|
| Cholesterol | 7 | 2013 | 2903 | 0.380 |
Why?
|
| Diet, Atherogenic | 1 | 2011 | 92 | 0.380 |
Why?
|
| Muscle Cells | 1 | 2012 | 194 | 0.370 |
Why?
|
| Immune Tolerance | 5 | 2015 | 2325 | 0.360 |
Why?
|
| B-Lymphocytes | 5 | 2021 | 4784 | 0.360 |
Why?
|
| Nitric Oxide | 2 | 2013 | 2141 | 0.350 |
Why?
|
| Cell Proliferation | 8 | 2021 | 10445 | 0.340 |
Why?
|
| Arachidonic Acids | 2 | 2001 | 295 | 0.330 |
Why?
|
| Antibodies | 3 | 2015 | 2421 | 0.320 |
Why?
|
| Neuralgia | 1 | 2016 | 618 | 0.320 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2413 | 0.320 |
Why?
|
| Monocytes | 2 | 2017 | 2600 | 0.320 |
Why?
|
| Ovalbumin | 8 | 2018 | 677 | 0.320 |
Why?
|
| Arteries | 3 | 2013 | 1123 | 0.310 |
Why?
|
| Peptides | 4 | 2011 | 4344 | 0.310 |
Why?
|
| T-Box Domain Proteins | 4 | 2011 | 471 | 0.310 |
Why?
|
| Receptors, Interferon | 1 | 2007 | 114 | 0.280 |
Why?
|
| Graft Rejection | 6 | 2011 | 4504 | 0.270 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 2006 | 897 | 0.270 |
Why?
|
| Mice, Inbred BALB C | 15 | 2018 | 6222 | 0.270 |
Why?
|
| Cell Migration Inhibition | 1 | 2006 | 97 | 0.270 |
Why?
|
| Behavior, Animal | 4 | 2021 | 1865 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 1805 | 0.260 |
Why?
|
| Interleukin-17 | 1 | 2012 | 923 | 0.260 |
Why?
|
| Lymph Nodes | 9 | 2021 | 3468 | 0.260 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2018 | 1535 | 0.250 |
Why?
|
| Lipoproteins | 4 | 2017 | 871 | 0.250 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 7 | 2016 | 692 | 0.250 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3250 | 0.250 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 1946 | 0.250 |
Why?
|
| Transcription Factors | 7 | 2014 | 12150 | 0.240 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2019 | 167 | 0.240 |
Why?
|
| Blood Vessels | 1 | 2010 | 1111 | 0.240 |
Why?
|
| Lipopeptides | 1 | 2024 | 73 | 0.230 |
Why?
|
| Coculture Techniques | 3 | 2016 | 1337 | 0.230 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 652 | 0.230 |
Why?
|
| Antigens, Differentiation | 1 | 2007 | 921 | 0.230 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 4904 | 0.220 |
Why?
|
| Aorta | 5 | 2015 | 2043 | 0.220 |
Why?
|
| Flow Cytometry | 9 | 2019 | 5890 | 0.220 |
Why?
|
| Intercellular Adhesion Molecule-1 | 7 | 2019 | 1131 | 0.210 |
Why?
|
| Hyperlipidemias | 2 | 2017 | 771 | 0.210 |
Why?
|
| Models, Immunological | 3 | 2017 | 517 | 0.210 |
Why?
|
| Neuropeptides | 3 | 2018 | 950 | 0.210 |
Why?
|
| Memory | 2 | 2004 | 2192 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 3 | 2016 | 9244 | 0.210 |
Why?
|
| Maze Learning | 2 | 2004 | 479 | 0.210 |
Why?
|
| Cell Adhesion Molecules | 4 | 2015 | 1612 | 0.200 |
Why?
|
| Cell Differentiation | 11 | 2020 | 11651 | 0.200 |
Why?
|
| Sialyltransferases | 1 | 2002 | 83 | 0.200 |
Why?
|
| Myocardium | 7 | 2019 | 4765 | 0.200 |
Why?
|
| Immunotherapy | 7 | 2021 | 4747 | 0.200 |
Why?
|
| Ligands | 4 | 2022 | 3275 | 0.200 |
Why?
|
| Apolipoproteins E | 6 | 2024 | 1459 | 0.200 |
Why?
|
| Autoantigens | 2 | 2018 | 886 | 0.190 |
Why?
|
| Lymphokines | 5 | 2007 | 924 | 0.190 |
Why?
|
| Morphine Dependence | 1 | 2001 | 27 | 0.190 |
Why?
|
| Opioid Peptides | 1 | 2001 | 37 | 0.190 |
Why?
|
| Extinction, Psychological | 1 | 2004 | 367 | 0.190 |
Why?
|
| Angiotensin II | 1 | 2024 | 844 | 0.190 |
Why?
|
| Leukocytes | 5 | 2019 | 2035 | 0.190 |
Why?
|
| Space Perception | 1 | 2004 | 468 | 0.190 |
Why?
|
| Transplantation, Homologous | 4 | 2011 | 4860 | 0.180 |
Why?
|
| Cell Communication | 4 | 2022 | 1660 | 0.180 |
Why?
|
| Whooping Cough | 1 | 2021 | 87 | 0.180 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2016 | 820 | 0.180 |
Why?
|
| Hallucinogens | 2 | 2001 | 212 | 0.180 |
Why?
|
| Mice, Inbred ICR | 5 | 2021 | 361 | 0.180 |
Why?
|
| Complement C3 | 1 | 2002 | 434 | 0.170 |
Why?
|
| Chaperonin 60 | 4 | 2004 | 97 | 0.170 |
Why?
|
| Cholates | 1 | 1999 | 4 | 0.170 |
Why?
|
| Receptors, IgG | 2 | 2021 | 562 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2017 | 10745 | 0.170 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 182 | 0.170 |
Why?
|
| Spleen | 5 | 2022 | 2295 | 0.170 |
Why?
|
| Lipid Metabolism | 3 | 2012 | 1895 | 0.170 |
Why?
|
| Narcotics | 1 | 2001 | 332 | 0.160 |
Why?
|
| Mice, Mutant Strains | 4 | 2012 | 1751 | 0.160 |
Why?
|
| Measles | 1 | 2021 | 180 | 0.160 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 1673 | 0.160 |
Why?
|
| Humans | 69 | 2024 | 766766 | 0.160 |
Why?
|
| Selectins | 1 | 1999 | 101 | 0.160 |
Why?
|
| Phenotype | 9 | 2018 | 16724 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7868 | 0.160 |
Why?
|
| Gene Expression | 3 | 2010 | 7585 | 0.160 |
Why?
|
| Antigens | 3 | 2022 | 1441 | 0.150 |
Why?
|
| I-kappa B Proteins | 1 | 1999 | 210 | 0.150 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2016 | 87 | 0.150 |
Why?
|
| Interleukin-1 | 4 | 1996 | 1251 | 0.150 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2011 | 661 | 0.150 |
Why?
|
| Bone Marrow Transplantation | 3 | 2018 | 2730 | 0.150 |
Why?
|
| Chlamydophila Infections | 2 | 2012 | 23 | 0.150 |
Why?
|
| Insect Control | 1 | 2018 | 28 | 0.150 |
Why?
|
| Autoimmunity | 4 | 2019 | 1358 | 0.150 |
Why?
|
| Nephritis | 2 | 2015 | 146 | 0.150 |
Why?
|
| Vasculitis | 2 | 2019 | 528 | 0.150 |
Why?
|
| Pheromones | 1 | 2018 | 93 | 0.140 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2018 | 179 | 0.140 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1791 | 0.140 |
Why?
|
| Kirsten murine sarcoma virus | 2 | 1987 | 5 | 0.140 |
Why?
|
| Sarcoma Viruses, Murine | 2 | 1987 | 18 | 0.140 |
Why?
|
| Oxidation-Reduction | 3 | 2013 | 2221 | 0.140 |
Why?
|
| Hydrolases | 1 | 2018 | 146 | 0.140 |
Why?
|
| Interleukin-10 | 2 | 2022 | 1182 | 0.140 |
Why?
|
| Morphine | 1 | 2001 | 658 | 0.140 |
Why?
|
| Foam Cells | 1 | 2017 | 68 | 0.140 |
Why?
|
| Antigens, Neoplasm | 2 | 2021 | 1998 | 0.140 |
Why?
|
| Heart Failure | 4 | 2018 | 11882 | 0.140 |
Why?
|
| Transcription Factor RelA | 2 | 2014 | 252 | 0.140 |
Why?
|
| Nicotine | 2 | 2015 | 680 | 0.140 |
Why?
|
| Kidney | 4 | 2018 | 7074 | 0.140 |
Why?
|
| Rhabdomyolysis | 1 | 2018 | 150 | 0.140 |
Why?
|
| Gene Expression Regulation | 11 | 2006 | 11920 | 0.130 |
Why?
|
| Trans-Activators | 3 | 2001 | 2855 | 0.130 |
Why?
|
| Heart Transplantation | 3 | 2011 | 3306 | 0.130 |
Why?
|
| Endothelium | 2 | 1997 | 768 | 0.130 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 1418 | 0.130 |
Why?
|
| Cholangiocarcinoma | 1 | 2021 | 562 | 0.130 |
Why?
|
| Egg Proteins | 2 | 2007 | 58 | 0.130 |
Why?
|
| Polysaccharides | 1 | 2002 | 1020 | 0.130 |
Why?
|
| N-Acetylglucosaminyltransferases | 3 | 2002 | 168 | 0.130 |
Why?
|
| Male | 34 | 2024 | 364142 | 0.130 |
Why?
|
| Cholesterol, VLDL | 1 | 2015 | 70 | 0.120 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2015 | 57 | 0.120 |
Why?
|
| Chemokines | 3 | 2016 | 962 | 0.120 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2016 | 381 | 0.120 |
Why?
|
| DNA-Binding Proteins | 8 | 2012 | 9611 | 0.120 |
Why?
|
| Apolipoprotein B-100 | 1 | 2015 | 157 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1105 | 0.120 |
Why?
|
| Interleukin-5 | 1 | 2015 | 268 | 0.120 |
Why?
|
| Growth Substances | 2 | 1987 | 759 | 0.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2024 | 1251 | 0.120 |
Why?
|
| Mast Cells | 1 | 2022 | 1405 | 0.120 |
Why?
|
| Receptors, CXCR3 | 2 | 2024 | 241 | 0.120 |
Why?
|
| Platelet Activation | 1 | 2018 | 643 | 0.120 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2014 | 103 | 0.110 |
Why?
|
| Fucosyltransferases | 3 | 2006 | 118 | 0.110 |
Why?
|
| Chlamydophila pneumoniae | 3 | 2012 | 53 | 0.110 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1995 | 282 | 0.110 |
Why?
|
| Receptors, Cannabinoid | 3 | 2007 | 43 | 0.110 |
Why?
|
| Hypertension | 2 | 2012 | 8616 | 0.110 |
Why?
|
| Apolipoproteins B | 1 | 2015 | 385 | 0.110 |
Why?
|
| Granzymes | 1 | 2015 | 278 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 1999 | 996 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 272 | 0.110 |
Why?
|
| Receptors, Scavenger | 1 | 2013 | 123 | 0.110 |
Why?
|
| Female | 30 | 2021 | 396520 | 0.100 |
Why?
|
| Cardiac Myosins | 1 | 2013 | 128 | 0.100 |
Why?
|
| NF-kappa B | 4 | 2000 | 2493 | 0.100 |
Why?
|
| Calcium | 7 | 1985 | 5783 | 0.100 |
Why?
|
| RNA, Messenger | 8 | 2015 | 12791 | 0.100 |
Why?
|
| CD40 Ligand | 2 | 2008 | 528 | 0.100 |
Why?
|
| Phagocytosis | 2 | 2016 | 1527 | 0.100 |
Why?
|
| Leukocyte Rolling | 1 | 2012 | 69 | 0.100 |
Why?
|
| Lipids | 3 | 2012 | 3319 | 0.100 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2012 | 110 | 0.100 |
Why?
|
| Neoplasms | 5 | 2024 | 22350 | 0.100 |
Why?
|
| Calcium-Transporting ATPases | 2 | 1982 | 122 | 0.100 |
Why?
|
| Chemokine CCL20 | 1 | 2012 | 64 | 0.100 |
Why?
|
| Macrophage-1 Antigen | 1 | 2012 | 286 | 0.100 |
Why?
|
| Lectins, C-Type | 1 | 2015 | 592 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 1110 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2011 | 2586 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2004 | 1494 | 0.090 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2011 | 29 | 0.090 |
Why?
|
| Clone Cells | 7 | 1994 | 1670 | 0.090 |
Why?
|
| Calgranulin A | 1 | 2011 | 81 | 0.090 |
Why?
|
| Receptors, Drug | 2 | 2001 | 156 | 0.090 |
Why?
|
| Disease Progression | 3 | 2024 | 13640 | 0.090 |
Why?
|
| Calgranulin B | 1 | 2011 | 87 | 0.090 |
Why?
|
| Serum | 1 | 2012 | 206 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2015 | 2160 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2015 | 554 | 0.090 |
Why?
|
| Integrin alpha4beta1 | 4 | 2016 | 119 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 167 | 0.090 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 4278 | 0.090 |
Why?
|
| Endoribonucleases | 1 | 2012 | 230 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2017 | 2085 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2017 | 843 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3053 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 1071 | 0.090 |
Why?
|
| Antibodies, Blocking | 1 | 2011 | 250 | 0.090 |
Why?
|
| Immunoglobulins | 2 | 2005 | 853 | 0.090 |
Why?
|
| Prenylation | 1 | 2010 | 37 | 0.090 |
Why?
|
| Acyl Coenzyme A | 1 | 2010 | 56 | 0.090 |
Why?
|
| Polyunsaturated Alkamides | 2 | 2001 | 29 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 996 | 0.090 |
Why?
|
| Apoptosis | 3 | 2016 | 9513 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 582 | 0.080 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2012 | 289 | 0.080 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2018 | 1352 | 0.080 |
Why?
|
| Alphapapillomavirus | 1 | 2012 | 219 | 0.080 |
Why?
|
| Thrombophilia | 1 | 2012 | 308 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1999 | 4522 | 0.080 |
Why?
|
| Histone Demethylases | 1 | 2012 | 328 | 0.080 |
Why?
|
| Receptors, Lymphocyte Homing | 2 | 2000 | 141 | 0.080 |
Why?
|
| Endocannabinoids | 2 | 2001 | 113 | 0.080 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 608 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1043 | 0.080 |
Why?
|
| Sodium, Dietary | 1 | 2012 | 426 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15908 | 0.080 |
Why?
|
| Spironolactone | 1 | 2012 | 415 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4570 | 0.080 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 5795 | 0.080 |
Why?
|
| Immunologic Memory | 3 | 2008 | 1377 | 0.080 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2214 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 2 | 2000 | 196 | 0.080 |
Why?
|
| Inflammasomes | 1 | 2013 | 541 | 0.070 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 17608 | 0.070 |
Why?
|
| Cardiology | 1 | 2019 | 1701 | 0.070 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2009 | 319 | 0.070 |
Why?
|
| Cell Line | 10 | 1998 | 15563 | 0.070 |
Why?
|
| Triglycerides | 1 | 2015 | 2441 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2604 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1197 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2019 | 2340 | 0.070 |
Why?
|
| TRPV Cation Channels | 1 | 2009 | 244 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 220 | 0.070 |
Why?
|
| Vas Deferens | 1 | 2007 | 55 | 0.070 |
Why?
|
| Leukemia Virus, Murine | 1 | 1987 | 95 | 0.070 |
Why?
|
| Models, Animal | 2 | 2015 | 2121 | 0.070 |
Why?
|
| Mice, Inbred AKR | 2 | 1999 | 103 | 0.070 |
Why?
|
| Graft Survival | 2 | 2015 | 3904 | 0.070 |
Why?
|
| Calcimycin | 3 | 1983 | 214 | 0.070 |
Why?
|
| Cyclosporine | 3 | 1999 | 778 | 0.070 |
Why?
|
| Clonal Deletion | 1 | 2006 | 75 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11061 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2430 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 752 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2019 | 2817 | 0.060 |
Why?
|
| Receptors, Leptin | 1 | 2007 | 352 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2012 | 828 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2008 | 880 | 0.060 |
Why?
|
| Thrombosis | 2 | 2018 | 2953 | 0.060 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1987 | 347 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2815 | 0.060 |
Why?
|
| Collagen | 2 | 2012 | 2635 | 0.060 |
Why?
|
| Time Factors | 6 | 2024 | 40149 | 0.060 |
Why?
|
| Immunologic Factors | 1 | 2014 | 1594 | 0.060 |
Why?
|
| Obesity | 1 | 2007 | 13090 | 0.060 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2005 | 93 | 0.060 |
Why?
|
| Transcription, Genetic | 6 | 2014 | 7609 | 0.060 |
Why?
|
| Lymphocyte Depletion | 1 | 2006 | 606 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 1627 | 0.060 |
Why?
|
| Retroviridae | 1 | 2006 | 846 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2270 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1987 | 546 | 0.060 |
Why?
|
| Hemorheology | 2 | 2001 | 144 | 0.060 |
Why?
|
| Phytohemagglutinins | 2 | 1982 | 164 | 0.060 |
Why?
|
| Drug Design | 1 | 2009 | 1042 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2014 | 1889 | 0.050 |
Why?
|
| Swimming | 1 | 2004 | 212 | 0.050 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2005 | 221 | 0.050 |
Why?
|
| Spectrophotometry, Atomic | 3 | 1985 | 80 | 0.050 |
Why?
|
| Lectins | 2 | 1983 | 490 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3531 | 0.050 |
Why?
|
| Integrins | 2 | 2000 | 839 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2021 | 582 | 0.050 |
Why?
|
| Peanut Agglutinin | 1 | 2002 | 19 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2007 | 5143 | 0.050 |
Why?
|
| Tryptophan Oxygenase | 1 | 2002 | 19 | 0.050 |
Why?
|
| Trifluoperazine | 1 | 1982 | 40 | 0.050 |
Why?
|
| Antigens, Ly | 1 | 2003 | 297 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2024 | 491 | 0.050 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2006 | 482 | 0.050 |
Why?
|
| Tobacco Use Disorder | 1 | 2008 | 708 | 0.050 |
Why?
|
| Rubella Vaccine | 1 | 2021 | 23 | 0.050 |
Why?
|
| Carotid Artery Diseases | 2 | 2018 | 872 | 0.050 |
Why?
|
| Mumps Vaccine | 1 | 2021 | 16 | 0.050 |
Why?
|
| Pain Threshold | 2 | 2007 | 606 | 0.050 |
Why?
|
| Aorta, Abdominal | 1 | 2024 | 627 | 0.050 |
Why?
|
| Kynurenine | 1 | 2002 | 142 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 316 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 13411 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 911 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2006 | 1260 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2004 | 707 | 0.050 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 880 | 0.050 |
Why?
|
| Reward | 1 | 2008 | 980 | 0.050 |
Why?
|
| Ethanolamines | 1 | 2001 | 152 | 0.050 |
Why?
|
| Base Sequence | 6 | 2005 | 12415 | 0.050 |
Why?
|
| Drug Implants | 1 | 2001 | 230 | 0.050 |
Why?
|
| Monokines | 2 | 1999 | 71 | 0.040 |
Why?
|
| Glucose | 1 | 2012 | 4340 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 624 | 0.040 |
Why?
|
| Papillomavirus Infections | 1 | 2012 | 1639 | 0.040 |
Why?
|
| Spatial Behavior | 1 | 2000 | 88 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 8045 | 0.040 |
Why?
|
| Receptors, Opioid, mu | 1 | 2001 | 167 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2003 | 557 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2000 | 118 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2012 | 8533 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2016 | 1838 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2003 | 827 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2003 | 1966 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2021 | 301 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 2021 | 512 | 0.040 |
Why?
|
| Receptor Aggregation | 1 | 1999 | 72 | 0.040 |
Why?
|
| Muscle, Smooth | 2 | 2018 | 931 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 1999 | 71 | 0.040 |
Why?
|
| Animal Feed | 1 | 1999 | 105 | 0.040 |
Why?
|
| Leptin | 1 | 2007 | 1596 | 0.040 |
Why?
|
| Tyrphostins | 1 | 1999 | 62 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 1996 | 5789 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2008 | 2392 | 0.040 |
Why?
|
| Mucins | 1 | 2022 | 569 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2003 | 1606 | 0.040 |
Why?
|
| Constriction | 1 | 2018 | 168 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2003 | 1194 | 0.040 |
Why?
|
| CHO Cells | 2 | 2000 | 1376 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2000 | 1377 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 1999 | 311 | 0.040 |
Why?
|
| Rheology | 1 | 1999 | 347 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 705 | 0.040 |
Why?
|
| Response Elements | 1 | 1999 | 308 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1716 | 0.040 |
Why?
|
| Aerosols | 1 | 2000 | 634 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 1999 | 420 | 0.040 |
Why?
|
| Deoxyribonuclease I | 1 | 2018 | 228 | 0.040 |
Why?
|
| Chlamydia trachomatis | 1 | 1999 | 239 | 0.030 |
Why?
|
| Brain | 3 | 2014 | 27159 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2009 | 3853 | 0.030 |
Why?
|
| Cricetinae | 2 | 2000 | 2416 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2000 | 1154 | 0.030 |
Why?
|
| Endocytosis | 1 | 2021 | 951 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1986 | 2839 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 4049 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2000 | 553 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 386 | 0.030 |
Why?
|
| Genotype | 1 | 2011 | 13036 | 0.030 |
Why?
|
| Cell Migration Assays, Leukocyte | 1 | 2015 | 8 | 0.030 |
Why?
|
| Kinetics | 5 | 1993 | 6287 | 0.030 |
Why?
|
| Glomerular Basement Membrane | 1 | 2015 | 35 | 0.030 |
Why?
|
| Ionomycin | 1 | 1996 | 109 | 0.030 |
Why?
|
| Tunica Intima | 1 | 2018 | 455 | 0.030 |
Why?
|
| Lung Transplantation | 1 | 2005 | 1310 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2000 | 736 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1999 | 637 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 562 | 0.030 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2015 | 100 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2019 | 548 | 0.030 |
Why?
|
| Ouabain | 1 | 1975 | 246 | 0.030 |
Why?
|
| Heart Block | 1 | 2016 | 391 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 1996 | 285 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2014 | 31 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1996 | 826 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2015 | 3587 | 0.030 |
Why?
|
| Diarrhea | 1 | 2001 | 1317 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 1999 | 1867 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1996 | 1550 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2014 | 792 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 2018 | 408 | 0.030 |
Why?
|
| Cytochrome Reductases | 1 | 1973 | 9 | 0.030 |
Why?
|
| Uncoupling Agents | 1 | 1973 | 46 | 0.030 |
Why?
|
| Myositis | 1 | 2016 | 268 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 3834 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8731 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2001 | 4142 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2142 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2003 | 2976 | 0.030 |
Why?
|
| Cell Division | 3 | 1988 | 4474 | 0.030 |
Why?
|
| Protein Binding | 3 | 2014 | 9320 | 0.030 |
Why?
|
| Endosomes | 1 | 2015 | 521 | 0.030 |
Why?
|
| Intradermal Tests | 1 | 2012 | 43 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 803 | 0.030 |
Why?
|
| Cell Death | 1 | 2018 | 1676 | 0.030 |
Why?
|
| Azepines | 1 | 2014 | 329 | 0.030 |
Why?
|
| Skin | 1 | 2006 | 4499 | 0.030 |
Why?
|
| Immunization | 1 | 2016 | 1218 | 0.030 |
Why?
|
| OX40 Ligand | 1 | 2012 | 57 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2012 | 109 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6214 | 0.020 |
Why?
|
| Acetylation | 1 | 2014 | 1054 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 2551 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15657 | 0.020 |
Why?
|
| Biological Transport, Active | 2 | 1982 | 323 | 0.020 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2011 | 92 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11872 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2011 | 511 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2021 | 2926 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2011 | 229 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 1993 | 6507 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 610 | 0.020 |
Why?
|
| Eosinophils | 1 | 1996 | 952 | 0.020 |
Why?
|
| K562 Cells | 1 | 2012 | 645 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2012 | 217 | 0.020 |
Why?
|
| Potassium | 1 | 1975 | 1314 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1992 | 565 | 0.020 |
Why?
|
| Histocompatibility | 1 | 2011 | 327 | 0.020 |
Why?
|
| Pain | 2 | 2009 | 5098 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3804 | 0.020 |
Why?
|
| Postprandial Period | 1 | 2012 | 320 | 0.020 |
Why?
|
| Down-Regulation | 1 | 1997 | 2931 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2014 | 549 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 2210 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 419 | 0.020 |
Why?
|
| Axilla | 1 | 2012 | 622 | 0.020 |
Why?
|
| Cell Membrane | 4 | 1983 | 3641 | 0.020 |
Why?
|
| Magnesium | 2 | 1985 | 815 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 2426 | 0.020 |
Why?
|
| Carboplatin | 1 | 2012 | 789 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1991 | 354 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 8106 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1993 | 2470 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 902 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2019 | 2645 | 0.020 |
Why?
|
| Body Weight | 1 | 1999 | 4626 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2009 | 9357 | 0.020 |
Why?
|
| RNA | 2 | 1993 | 2715 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2533 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1363 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1991 | 812 | 0.020 |
Why?
|
| Trinitrobenzenes | 1 | 1987 | 45 | 0.020 |
Why?
|
| Dinitrophenols | 2 | 1980 | 56 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2012 | 1651 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2011 | 1442 | 0.020 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1987 | 69 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1927 | 0.020 |
Why?
|
| Middle Aged | 7 | 2021 | 223257 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2016 | 2158 | 0.020 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2007 | 48 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1996 | 2870 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2012 | 714 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1996 | 2448 | 0.020 |
Why?
|
| Cyanides | 2 | 1980 | 82 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 2258 | 0.020 |
Why?
|
| Cyclohexanes | 1 | 2007 | 151 | 0.020 |
Why?
|
| Cyclohexanols | 1 | 2007 | 126 | 0.020 |
Why?
|
| Cisplatin | 1 | 2012 | 1655 | 0.020 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2012 | 794 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 4752 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 810 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2007 | 198 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1718 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3944 | 0.020 |
Why?
|
| Lymphoma | 1 | 1975 | 1900 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1987 | 342 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1996 | 1941 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2007 | 1141 | 0.020 |
Why?
|
| Benzoxazines | 1 | 2007 | 320 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2012 | 1727 | 0.020 |
Why?
|
| Echocardiography | 1 | 2017 | 5037 | 0.010 |
Why?
|
| Models, Biological | 1 | 2001 | 9461 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 2901 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4853 | 0.010 |
Why?
|
| Diet | 2 | 1999 | 8088 | 0.010 |
Why?
|
| Dura Mater | 1 | 1986 | 292 | 0.010 |
Why?
|
| Locomotion | 1 | 2007 | 388 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 3609 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 6066 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 23717 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1986 | 1767 | 0.010 |
Why?
|
| Histones | 1 | 2014 | 2593 | 0.010 |
Why?
|
| RNA Interference | 1 | 2012 | 2827 | 0.010 |
Why?
|
| Interleukins | 1 | 1988 | 795 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2028 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 1938 | 0.010 |
Why?
|
| Morpholines | 1 | 2007 | 584 | 0.010 |
Why?
|
| Body Temperature | 1 | 2007 | 780 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 7571 | 0.010 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2007 | 371 | 0.010 |
Why?
|
| Cell Count | 2 | 1979 | 1826 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3425 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2016 | 6408 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 1994 | 3041 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6779 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6329 | 0.010 |
Why?
|
| Phenols | 1 | 2007 | 526 | 0.010 |
Why?
|
| Mitogens | 1 | 1983 | 229 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1983 | 340 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 2704 | 0.010 |
Why?
|
| Chromatin | 1 | 2014 | 2977 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1987 | 1392 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1982 | 199 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1982 | 189 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2007 | 1208 | 0.010 |
Why?
|
| STAT4 Transcription Factor | 1 | 2001 | 94 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2823 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2007 | 1736 | 0.010 |
Why?
|
| Ferric Compounds | 1 | 2003 | 376 | 0.010 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2002 | 117 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 1604 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1981 | 165 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1980 | 7475 | 0.010 |
Why?
|
| Carcinoma | 1 | 2012 | 2324 | 0.010 |
Why?
|
| Risk Factors | 2 | 2019 | 74881 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 1992 | 361 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 689 | 0.010 |
Why?
|
| Calmodulin | 1 | 1981 | 239 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1986 | 908 | 0.010 |
Why?
|
| Tryptophan | 1 | 2002 | 484 | 0.010 |
Why?
|
| Chlamydia | 1 | 2000 | 33 | 0.010 |
Why?
|
| Ethylene Glycols | 1 | 1981 | 196 | 0.010 |
Why?
|
| Cholic Acid | 1 | 1999 | 30 | 0.010 |
Why?
|
| Azides | 1 | 1980 | 120 | 0.010 |
Why?
|
| Particle Size | 1 | 2003 | 1634 | 0.010 |
Why?
|
| Trachea | 1 | 2005 | 1094 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1981 | 479 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15416 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3989 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2002 | 1750 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29948 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2003 | 702 | 0.010 |
Why?
|
| Melanoma | 1 | 2016 | 5700 | 0.010 |
Why?
|
| Insulin | 1 | 2012 | 6608 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2012 | 6422 | 0.010 |
Why?
|
| Leishmania major | 1 | 1997 | 60 | 0.010 |
Why?
|
| DNA Replication | 1 | 1985 | 1426 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11218 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 24295 | 0.010 |
Why?
|
| Endotoxins | 1 | 2000 | 519 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 12985 | 0.010 |
Why?
|
| Zinc | 1 | 1981 | 675 | 0.010 |
Why?
|
| Meningeal Neoplasms | 1 | 1986 | 1255 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 693 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9525 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2007 | 3576 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1657 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6550 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 1996 | 127 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36567 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1525 | 0.010 |
Why?
|
| Young Adult | 2 | 2012 | 59939 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 1997 | 392 | 0.010 |
Why?
|
| Rubidium | 1 | 1975 | 120 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 10384 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2002 | 1852 | 0.010 |
Why?
|
| Deoxyribonucleoproteins | 1 | 1994 | 3 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1981 | 2001 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 1244 | 0.010 |
Why?
|
| Adult | 3 | 2015 | 223307 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 30213 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1998 | 2275 | 0.010 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1996 | 271 | 0.010 |
Why?
|
| Cholic Acids | 1 | 1973 | 39 | 0.010 |
Why?
|
| Phenylhydrazines | 1 | 1973 | 28 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1973 | 123 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 766 | 0.010 |
Why?
|
| Naphthoquinones | 1 | 1973 | 60 | 0.010 |
Why?
|
| Succinates | 1 | 1973 | 83 | 0.010 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1993 | 67 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1975 | 509 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1973 | 291 | 0.010 |
Why?
|
| Azacitidine | 1 | 1994 | 335 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1993 | 439 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 1989 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 1973 | 171 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6104 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 171343 | 0.010 |
Why?
|
| Methylation | 1 | 1994 | 1074 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1996 | 2177 | 0.010 |
Why?
|
| Chlorides | 1 | 1994 | 666 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 20708 | 0.010 |
Why?
|
| Genes | 1 | 1994 | 1824 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 1998 | 1730 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4168 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1997 | 2669 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1990 | 341 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1993 | 1228 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1994 | 1339 | 0.000 |
Why?
|
| Interleukin-6 | 1 | 1999 | 3227 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 11513 | 0.000 |
Why?
|
| Quinolines | 1 | 1973 | 769 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2012 | 54871 | 0.000 |
Why?
|
| Cattle | 1 | 1973 | 3815 | 0.000 |
Why?
|
| Stroke | 1 | 2009 | 9741 | 0.000 |
Why?
|
| DNA | 1 | 1980 | 7208 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 88904 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1982 | 141 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1982 | 292 | 0.000 |
Why?
|
| Colony-Stimulating Factors | 1 | 1982 | 218 | 0.000 |
Why?
|
| Subcellular Fractions | 1 | 1982 | 526 | 0.000 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1982 | 324 | 0.000 |
Why?
|
| Fibrinolysis | 1 | 1982 | 331 | 0.000 |
Why?
|
| Carrier Proteins | 1 | 1994 | 4924 | 0.000 |
Why?
|
| Mathematics | 1 | 1981 | 696 | 0.000 |
Why?
|
| Erythropoiesis | 1 | 1982 | 692 | 0.000 |
Why?
|
| Proteins | 1 | 1982 | 6002 | 0.000 |
Why?
|